[1] ZALETA A K,MILLER M F,OLSON J S,et al. Symptom burden,perceived control,and quality of life among patients living with multiple myeloma[J]. J Natl Compr Canc Netw,2020,18(8):1087-1095.
[2] LOTFI-JAM K,GOUGH K,SCHOFIELD P,et al. A longitudinal study of four unique trajectories of psychological distress in cancer survivors after completing potentially curative treatment[J]. Acta Oncol,2019,58(5):782-789.
[3] BONANNO G A. Loss,trauma,and human resilience: have we underestimated the human capacity to thrive after extremely aversive events?[J]. Am Psychol,2004,59(1):20-28.
[4] BONANNO G A,WESTPHAL M,MANCINI A D. Resilience to loss and potential trauma[J]. Annu Rev Clin Psychol,2011,7:511-535.
[5] SAGAR S M. Integrative oncology:are we doing enough to integrate psycho-education?[J]. Future Oncol,2016,12(24):2779-2783.
[6] de GROOT J,BULTZ B D. 心理社会肿瘤学在中国的发展现状——机会与挑战(英文)[J]. Chin Germ J Clin Oncol,2009,8(3):123-128.
[7] SPITZER R L,KROENKE K,WILLIAMS J B,et al. A brief measure for assessing generalized anxiety disorder: the GAD-7[J]. Arch Intern Med,2006,166(10):1092-1097.
[8] KROENKE K,SPITZER R L,WILLIAMS J B. The PHQ-9: validity of a brief depression severity measure[J]. J Gen Intern Med,2001, 16(9):606-613.
[9] STEEL Z,MARNANE C,IRANPOUR C,et al. The global prevalence of common mental disorders: a systematic review and meta-analysis 1980-2013[J]. Int J Epidemiol,2014,43(2):476-493.
[10] MITCHELL A J,CHAN M,BHATTI H,et al. Prevalence of depression,anxiety,and adjustment disorder in oncological,haematological,and palliative-care settings: a meta-analysis of 94 interview-based studies[J]. Lancet Oncol,2011,12(2):160-174.
[11] VLISEN A K,JAKOBSEN L H,KRAGHOLM K H,et al. Depression and anxiety in Hodgkin lymphoma patients: a Danish nationwide cohort study of 945 patients[J]. Cancer Med,2020,9(12):4395-4404.
[12] BROCHMANN N,FLACHS E M,CHRISTENSEN A I,et al. Anxiety and depression in patients with Philadelphia-negative myeloproliferative neoplasms: a nationwide population-based survey in Denmark[J]. Clin Epidemiol,2019,11:23-33.
[13] EL-JAWAHRI A,ABEL G A,TRAEGER L,et al. Quality of life and mood of older patients with acute myeloid leukemia(AML) receiving intensive and non-intensive chemotherapy[J]. Leukemia,2019,33(10):2393-2402.
[14] SOGAWA R,KIMURA S,YAKABE R,et al. Anxiety and depression associated with tyrosine kinase inhibitor discontinuation in patients with chronic myeloid leukemia[J]. Int J Clin Oncol,2018,23(5):974-979.
[15] FALTER T,B?魻SCHEN S,SCHEPERS M,et al. Influence of personality,resilience and life conditions on depression and anxiety in 104 patients having survived acute autoimmune thrombotic thrombocytopenic purpura[J]. J Clin Med,2021,10(2):365.
[16] RIVA S,MANCINI I,MAINO A,et al. Long-term neuropsychological sequelae,emotional wellbeing and quality of life in patients with acquired thrombotic thrombocytopenic purpura[J]. Haematologica,2020,105(7):1957-1962.
[17] TORRES-ORTU ?譙 O A,CUESTA-BARRIUSO R,NIETO-MUNUERA J,et al. Coping strategies in young and adult haemophilia patients:a tool for the adaptation to the disease[J]. Haemophilia,2019,25(3):392-397.
[18] ZOLALY M A,ZOLALY F M,AL BELOWI L,et al. Depression,anxiety,and stress symptoms in patients with beta thalassemia major in Almadinah Almunawwarah,Saudi Arabia[J]. Cureus,2020,12(11):e11367.
[19] AL-HAKEIM H K,NAJM A H,AL-DUJAILI A H,et al. Major depression in children with transfusion-dependent thalassemia is strongly associated with the combined effects of blood transfusion rate,iron overload,and increased pro-inflammatory cytokines[J]. Neurotox Res,2020,38(1):228-241.